We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$32.1M |
| 2 |
Intel
INTC
|
+$28.7M |
| 3 |
Gilead Sciences
GILD
|
+$27.7M |
| 4 |
APA Corp
APA
|
+$27.5M |
| 5 |
Costco
COST
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OPTU
Optimum Communications Inc
OPTU
|
+$41M |
| 2 |
Align Technology
ALGN
|
+$38.9M |
| 3 |
Qualcomm
QCOM
|
+$33.6M |
| 4 |
H&R Block
HRB
|
+$31.8M |
| 5 |
CBRE Group
CBRE
|
+$28.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Healthcare | 14.08% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 13.05% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Pacira BioSciences
PCRX
$1.04B
| $3.29M | 0.03% |
55,041
-4,723
| -8% | -$277K |
|
477
First Bancorp
FBP
$4.42B
| $3.29M | 0.03% |
356,718
-75,789
| -18% | -$578K |
|
478
SPS Commerce
SPSC
$2.64B
| $3.28M | 0.03% |
30,243
-23,773
| -44% | -$2.23M |
|
479
Amneal Pharmaceuticals
AMRX
$5.85B
| $3.27M | 0.03% |
714,819
+414,546
| +138% | +$1.84M |
|
|
REVG
480
DELISTED
REV Group
REVG
| $3.22M | 0.03% |
365,620
+12,268
| +3% | +$109K |
|
481
DXP Enterprises
DXPE
$2.43B
| $3.18M | 0.03% |
142,888
-1,421
| -1% | -$28.7K |
|
482
Sturm, Ruger & Co
RGR
$594M
| $3.16M | 0.03% |
48,546
-54,542
| -53% | -$3.51M |
|
|
QADA
483
DELISTED
QAD Inc.
QADA
| $3.15M | 0.03% |
49,865
-3,212
| -6% | -$165K |
|
|
SNCR
484
DELISTED
Synchronoss Technologies
SNCR
| $3.14M | 0.03% |
74,164
+97
| +0.1% | +$2.81K |
|
|
LCI
485
DELISTED
Lannett Company, Inc.
LCI
| $3.12M | 0.03% |
119,713
+2,681
| +2% | +$70K |
|
486
Gogo Inc
GOGO
$565M
| $3.12M | 0.03% |
323,538
-161,999
| -33% | -$1.6M |
|
487
Matrix Service
MTRX
$326M
| $3.12M | 0.03% |
282,768
-23,749
| -8% | -$219K |
|
488
Universal Display
OLED
$3.68B
| $3.08M | 0.03% |
13,388
-6,965
| -34% | -$1.49M |
|
489
QCR Holdings
QCRH
$1.69B
| $3.05M | 0.03% |
77,081
-555
| -0.7% | -$19.4K |
|
490
FB Financial Corp
FBK
$3.02B
| $3.05M | 0.03% |
87,827
-12,047
| -12% | -$379K |
|
|
ABMD
491
DELISTED
Abiomed Inc
ABMD
| $3.04M | 0.03% |
9,386
-45,506
| -83% | -$12.6M |
|
|
WIFI
492
DELISTED
Boingo Wireless, Inc.
WIFI
| $3.04M | 0.03% |
238,729
-12,313
| -5% | -$145K |
|
493
Ribbon Communications
RBBN
$377M
| $3.04M | 0.03% |
462,825
-2,763
| -0.6% | -$14.6K |
|
|
CHMA
494
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.03M | 0.03% |
696,246
+426,259
| +158% | +$1.78M |
|
495
Arista Networks
ANET
$227B
| $3M | 0.03% |
165,088
-1,368,480
| -89% | -$21.7M |
|
|
RUBY
496
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3M | 0.03% |
394,909
-7,646
| -2% | -$45.4K |
|
497
Lakeland Industries
LAKE
$113M
| $2.97M | 0.03% |
+109,097
| New | +$2.47M |
|
498
AngioDynamics
ANGO
$611M
| $2.93M | 0.03% |
191,376
+15,799
| +9% | +$200K |
|
499
Service Corp International
SCI
$11.7B
| $2.93M | 0.03% |
59,742
+54,321
| +1,002% | +$2.58M |
|
500
Orion
OEC
$381M
| $2.91M | 0.03% |
169,840
-27,560
| -14% | -$420K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2020 Portfolio in Review
As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
- Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
- Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
- Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
- Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.